| Tag | Content |
|---|
EnhancerAtlas ID | HS176-14676 |
Organism | Homo sapiens |
Tissue/cell | SK-N-SH |
Coordinate | chr16:1771930-1772790 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| FOS | MA0476.1 | chr16:1772342-1772353 | AATGAGTCACC | - | 6.02 | | JUN(var.2) | MA0489.1 | chr16:1772343-1772357 | ATGAGTCACCTCTT | - | 7.08 | | RUNX1 | MA0002.2 | chr16:1772307-1772318 | CTCTGTGGTTT | + | 6.14 | | Zfx | MA0146.2 | chr16:1772014-1772028 | CCCGCCTCGGCCTC | + | 6.01 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_10840 | chr16:1772015-1772748 | CD19_Primary | | SE_47423 | chr16:1771034-1773029 | Panc1 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH16I001720 | chr16 | 1770940 | 1774290 |
|
Enhancer Sequence | CAGCTAATTT TTTTTATTTT TAGTAGAAAC GGGGTTTCAC CATGTTAGCC AGGAAGGTCT 60
CCATCTCCTG ACCTCGTCAT CCCCCCCGCC TCGGCCTCCC AGAGTGCTGG GATTACAGGC 120
GTGAGCCACC GCACCCAGAC AACTTTTTGT TAAAAATTCT TATCAGTCGA TTAATAGCAT 180
GTGTGTGTTC TTCATATGCT AGTTAGCCAC AGTTAATTCA AAATCACTTA TTTTTATTTT 240
TTGTACCGCC GCACAAAAAA GTCATGCATT TTCTCAGCTG TGGAGTGTTT GTTTTTCTTC 300
CTTTTCCTTA AGTTGCATGT GATGCCCATA ACACAGACTC TTCCTGCTGC CTCCTGCTCC 360
CTGCCTGCCC CTCCCGCCTC TGTGGTTTTC TGCCCTCTCA GTAACTGCAC AGAATGAGTC 420
ACCTCTTGGG CAGAGCCCCA GTGGTTTCAA CACAAAGACC TTTTTAGAAG CTGCTGCTAT 480
AGGAAGAAGC GTCGAGGAGC CTAGTATCCG GGTGGGAGAG TGGGTAGAGT TATTATAGGG 540
AACACAGCTG TGGCCACTAC CCATGGATCT TCCAGATCCC AAAAGATGAA ATCCACCACC 600
CGGTTTATAT TCCCATCTTC TGAGAAACTC TTTTGTCTTC AGAACCCAGC TGAGGCTGGG 660
TGCAGTCGCT CAGGCCTATA ATCCCAGCGC TTTGGGAGGC TGAGGTGGGA GGATCGCTTG 720
AGCCCAGGAG TTTGAGACCA ACCTGGGAAC CATAGCAAGA CCCCATCTCA AAAAAAAAAA 780
AAATCTTTTT TTTGAGATGG AGTCTCGCTC TGTCGCCCAG GCTGGAGTGC GGTGGCGCTA 840
TCTTGGCTCA CTACAAGCTC 860
|
